News

Does Valero Energy (VLO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Apple may soon need to make up its mind about spending on AI. It resisted developing its own AI models, relying instead on OpenAI to fuel its AI strategy under a 2024 deal. Earlier this year, it abandoned OpenAI in favor of Google’s Gemini, which is set to power a revamped AI-infused version of its Siri digital assistant.

Anthropic has signed a $10 billion, six-year deal for computing capacity with Volta Infra Holdings, a cloud infrastructure startup backed by Nvidia Corp (NASDAQ:NVDA, XETRA:NVD), according to media reports citing people familiar with the matter, as the Claude maker moves to secure additional...

Autodesk currently trades at $246.30 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.

Wayfair’s free cash flow came in at $301 million, compared to $230 million last year, which the company claims was its strongest since 2020.

EME's record backlog, AI infrastructure demand and acquisitions are strengthening growth, as it lifts its 2026 revenue and earnings outlook.

CoreWeave stock rose after the artificial intelligence data center builder said it will expand in Asia-Pacific markets.

Crispr Therapeutics (CRSP) reported a relatively quiet Q2, with Casgevy continuing to gain commercia

A second markup in 4 months puts Polymarket’s revenue and volume numbers on full display, but its chief rival is still setting the pace in the valuation race

Block heads into the Q2 earnings release with 20% gross profit growth targeted, Cash App and Square momentum, and bitcoin volatility shaping the outlook.

Spotify (SPOT) issued a stronger-than-expected third-quarter revenue outlook, even though it said ce

If you're invested in telecoms, you need to put SpaceX's earnings report on your radar. The disruption that SpaceX represents has been a stressor ever since June 12 -- SpaceX's IPO date--when company President Gwynne Shotwell told CNBC that the opportunity for Starlink Mobile was huge. Shares bottomed out near $20 in early July, then recovered as SpaceX started to drop.

Reaching the next milestone takes about a 31% climb. The current pace of profit growth would more than cover it.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Citigroup (C) have what it takes? Let's find out.

Brent crude fell back to around $80 per barrel after renewed optimism over a potential US-Iran draft agreement eased geopolitical fears

“It's very hard as an entrepreneur when you're working out of your apartment, to know what that size could be one day,” DoorDash cofounder Tony Xu said.

Pfizer beats Q2 earnings and revenue estimates, raises the low end of its 2026 sales outlook, but lowers expectations for COVID product revenues.

SIMO's shares slid despite record results as AI, enterprise storage and automotive growth fuel rising revenue and another quarter of strong guidance.

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 10.2% year on year to $16.99 billion. Its non-GAAP profit of $3.65 per share was 1.2% above analysts’ consensus estimates.

NICE vs. ZM: Which Stock Is the Better Value Option?

TRIP vs. EBAY: Which Stock Is the Better Value Option?

BMY vs. AMGN: Which Stock Is the Better Value Option?

SIMO is expanding into AI infrastructure and enterprise SSD controllers as commercial production ramps and new customer deployments broaden its growth opportunities.

The acquisition, which was first announced in June, brings Vibe.co into Walmart Connect, Walmart's connected TV advertising platform.

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

Coca-Cola and PepsiCo are taking very different paths through the health-conscious-beverage boom, and one is pulling away in a big way.

Goldman Sachs just handed Microsoft its most coveted endorsement while cutting three other tech giants loose, and the reasoning behind that trade reveals exactly where Wall Street thinks the AI money flows next.

Alternative asset manager Ares Management (NYSE:ARES) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 25.6% year on year to $1.28 billion. Its non-GAAP profit of $1.29 per share was 1.4% above analysts’ consensus estimates.

While Morgan Stanley has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.